Table 3.
Identification of risk factors for large hematoma by univariate analysis
| Variable | Mild to moderate hematoma (n = 123) | Large hematoma (n = 88) | P value |
|---|---|---|---|
| Age, mean ± SD (year) | 56.57 ± 11.61 | 56.49 ± 12.55 | 0.059a |
| Male sex [n (%)] | 79 (64.2) | 63 (71.6) | 0.261b |
| BMI, median (IQR) (kg/m2) | 23.30 (21.95–24.51) | 23.77 (22.44–24.96) | 0.226c |
| Smoking history [n (%)] | 16 (13.0) | 22 (25.0) | 0.025b |
| Alcohol history [n (%)] | 11 (8.9) | 16 (18.2) | 0.048b |
| Hypertension [n (%)] | 97 (78.9) | 54 (61.4) | 0.005b |
| Diabetes mellitus [n (%)] | 2 (1.6) | 1 (1.1) | 1.000b |
| Coronary heart disease [n (%)] | 6 (4.9) | 7 (8.0) | 0.359b |
| Stroke history [n (%)] | 8 (6.5) | 9 (10.2) | 0.327b |
| Antithrombotic agent history [n (%)] | 4 (3.3) | 2 (2.3) | 0.998b |
| Supratentorial hemorrhage [n (%)] | |||
| Basal ganglia | 45 (36.6) | 37 (42.0) | 0.422b |
| Lobar | 37 (30.1) | 29 (33.0) | 0.657b |
| Thalamus | 32 (26.0) | 22 (25.0) | 0.868b |
| Infratentorial hemorrhage [n (%)] | |||
| Brainstem | 9 (7.3) | 7 (8.0) | 0.863b |
| Cerebellum | 7 (5.7) | 7 (8.0) | 0.515b |
| IVH [n (%)] | 40 (32.5) | 66 (75) | < 0.001b |
| SAH [n (%)] | 10 (8.1) | 25 (28.4) | < 0.001b |
| Laboratory examination | |||
| TG, median (IQR) (mmol/l) | 1.00 (0.81–1.43) | 0.87 (0.64–1.25) | 0.011c |
| HDL, mean ± SD (mmol/l) | 1.16 ± 0.34 | 1.28 ± 0.35 | 0.012a |
| LDL, mean ± SD (mmol/l) | 2.50 ± 0.94 | 2.34 ± 0.87 | 0.215a |
| TC, mean ± SD (mmol/l) | 4.08 ± 1.14 | 4.05 ± 1.07 | 0.811a |
| Hemoglobin, mean ± SD (g/l) | 157.95 ± 29.86 | 174.92 ± 37.29 | 0.001a |
| Platelet count, mean ± SD (109/l) | 201.19 ± 77.03 | 170.31 ± 58.77 | 0.001a |
BMI body mass index, HDL high-density lipoprotein cholesterol, IQR interquartile range, IVH intraventricular hemorrhage, LDL low-density lipoprotein cholesterol, SAH subarachnoid hemorrhage, SD standard deviation, TC total cholesterol, TG triglycerides
aStudent’s t-test
bχ2 test
cMann–Whitney U-test